The potential use of miRNAs as biomarkers in complement-mediated renal pathologies

被引:0
|
作者
Gutierrez-Tenorio, Josue [1 ]
Caravaca, Fernando [2 ]
Lucientes, Laura [1 ]
Llamas, Adara [1 ]
Marquez, Barbara [1 ]
Praga, Manuel [2 ]
Goicoechea de Jorge, Elena [1 ]
机构
[1] Univ Complutense Madrid, Res Inst Hosp Octubre 12, Dept Immunol, Madrid, Spain
[2] Res Inst Hosp 12 Octubre Imas12, Dept Nephrol, Madrid, Spain
关键词
Complement system; Renal disease; MicroRNAs; Biomarkers;
D O I
10.1016/j.molimm.2018.06.086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
071
引用
收藏
页码:158 / 158
页数:1
相关论文
共 50 条
  • [1] Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders
    Wehling, C.
    Amon, O.
    Bommer, M.
    Hoppe, B.
    Kentouche, K.
    Schalk, G.
    Weimer, R.
    Wiesener, M.
    Hohenstein, B.
    Toenshoff, B.
    Buescher, R.
    Fehrenbach, H.
    Goek, Oe. -N.
    Kirschfink, M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2017, 187 (02): : 304 - 315
  • [2] Complement Factor I Variants in Complement-Mediated Renal Diseases
    Zhang, Yuzhou
    Goodfellow, Renee X.
    Ghiringhelli Borsa, Nicolo
    Dunlop, Hannah C.
    Presti, Stephen A.
    Meyer, Nicole C.
    Shao, Dingwu
    Roberts, Sarah M.
    Jones, Michael B.
    Pitcher, Gabriella R.
    Taylor, Amanda O.
    Nester, Carla M.
    Smith, Richard J. H.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] Complement-mediated renal injury: Mechanisms and role of membrane regulators of complement
    Seiichi Matsuo
    Yoshiki Morita
    Masashi Mizuno
    Kazuhiro Nishikawa
    Yukio Yuzawa
    Clinical and Experimental Nephrology, 1998, 2 (4) : 276 - 281
  • [4] COMPLEMENT-MEDIATED TMA IN A PATIENT WITH SCLERODERMA RENAL CRISIS
    Ludwig, Micah
    Sparks, Matthew
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2025, 85 (04)
  • [5] NEW INSIGHTS INTO THE PATHOPHYSIOLOGY AND CLASSIFICATION OF COMPLEMENT-MEDIATED RENAL DISEASES
    Garam, Nora
    Szilagyi, Agnes
    Prohaszka, Zoltan
    Csuka, Dorottya
    MOLECULAR IMMUNOLOGY, 2019, 114 : 457 - 457
  • [6] Extra-renal manifestations of complement-mediated thrombotic microangiopathies
    Hofer, Johannes
    Rosales, Alejandra
    Fischer, Caroline
    Giner, Thomas
    FRONTIERS IN PEDIATRICS, 2014, 2
  • [7] NEW INSIGHTS INTO THE PATHOPHYSIOLOGY AND CLASSIFICATION OF COMPLEMENT-MEDIATED RENAL DISEASES
    Garam, Nora
    Prohaszka, Zoltan
    Csuka, Dorotty
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [8] Potential Use of miRNAs as Platelet Biomarkers of Storage
    Kannan, Mecanathan
    Mohan, Ketha V. K.
    Kulkarni, Sandhya
    Atreya, Chintamani D.
    BLOOD, 2008, 112 (11) : 695 - 695
  • [9] Omics-based approach reveals complement-mediated inflammation in CLIPPERS and potential biomarkers differentiating from RRMS
    Blaabjerg, M.
    Hemdrup, A. L.
    Drici, L.
    Ruprecht, K.
    Garred, P.
    Hoeftberger, R.
    Christensen, B. W.
    Kondziella, D.
    Sejbaek, T.
    Hansen, S. W. K.
    Nielsen, H. H.
    Jensen, P.
    Meyer, M.
    Paul, F.
    Lassmann, H.
    Larsen, M. R.
    Illes, Z.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 429 - 429
  • [10] Complement-mediated kidney diseases
    Poppelaars, Felix
    Thurman, Joshua M.
    MOLECULAR IMMUNOLOGY, 2020, 128 : 175 - 187